Target intelligence / Profile preview

BTBD9 antisense RNA 1 (BTBD9-AS1)

Target
BTBD9-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

BTBD9 antisense RNA 1 (BTBD9-AS1) is a long non-coding antisense RNA located on human chromosome 6, transcribed on the opposite strand relative to the BTBD9 gene[5][8]. As an lncRNA, BTBD9-AS1 does not code for proteins but is believed to have regulatory functions at the RNA level, potentially influencing the expression of the BTBD9 gene or other nearby genes through mechanisms such as transcriptional interference or chromatin remodeling[1][3][4][7]. While BTBD9 itself has been linked genetically to restless legs syndrome and regulation of neural and motor pathways, there is currently insufficient evidence to establish BTBD9-AS1 as a direct therapeutic target or to attribute specific disease roles to it. The study of lncRNAs like BTBD9-AS1 is an active field, and future research may clarify their functional and clinical significance[3][4][6]. Key points about BTBD9-AS1: - Canonical non-coding transcript, not a protein, enzyme, or receptor. - Acts primarily via gene regulation, especially in neural tissues. - No direct therapeutic interventions, drugs, or biomarker uses currently established. - Not a classical therapeutic target.

Other names
BTBD9-AS1BTBD9 antisense RNA 1 (non-protein coding)BTBD9 antisense RNA 1
02

Biological functions

Regulation of gene expressionPossible roles in neural pathway activity and motor regulation (by analogy with BTBD9 function, though direct evidence for BTBD9-AS1 is limited)
03

Disease associations

Other (no direct evidence for major diseases; the protein-coding BTBD9 gene is associated with restless legs syndrome, but a specific disease association for BTBD9-AS1 is not established)

Beyond the preview

Go deeper on BTBD9 antisense RNA 1 (BTBD9-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTBD9 antisense RNA 1 (BTBD9-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call